Post-Marketing surveillance for HPV infection related serious disease in a cohort of Chinese women who received GARDASIL® and GARDASIL®9 (V503-107)

19/11/2026
19/11/2026
EU PAS number:
EUPAS1000001165
Study
Planned
Documents
Study protocol
Initial protocol
English (460.45 KB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.